Skip to main content
. 2020 Oct 12;10(12):e01885. doi: 10.1002/brb3.1885

Table 2.

Clinical variable between PD patients and healthy controls

PD HC t p value
BDNF level (ng/ml) a 16.9 (9.6) 21.5 (8.8) −3.25 .001
TMT‐A a 48.0 (21.0) 41.5 (14.2) 2.38 .019
BACS SC a 43.9 (12.9) 49.0 (13.5) −2.60 .010
HVLT‐R a 20.4 (5.1) 20.7 (4.2) −0.38 .704
BVMT‐R a 22.0 (6.2) 23.5 (5.9) −1.67 .096
Stroop word a 84.0 (14.4) 86.0 (15.8) −0.88 .378
Stroop color a 59.9 (12.7) 64.5 (16.4) −2.08 .039
Stroop interference a 34.2 (9.8) 40.5 (11.4) −3.92 <.001
Total stroop a 178.0 (29.3) 190.9 (38.8) −2.50 .013
Visual‐spatial abilities a 4.3 (0.9) 4.6 (0.6) −2.88 .005
Abstract 1.6 (0.5) 1.9 (0.3) −5.31 <.001
Attention and concentration a 4.6 (0.8) 5.0 (1.0) −2.93 .004
Language a 2.5 (0.6) 2.7 (0.4) −3.29 .001
Delayed memory a 2.5 (1.7) 4.2 (0.8) −8.64 <.001
Orientation a 5.9 (0.2) 5.9 (0.3) 0.19 .847
Total MoCA a 24.3 (2.8) 27.4 (1.6) −8.91 <.001

Abbreviations: BACS SC, Brief Assessment of Cognition in Schizophrenia Symbol Coding subtest; BVMT‐R, Brief Visuospatial Memory Test ‐Revised; HC, healthy control; HVLT‐R, Hopkins Verbal Learning Test—Revised; PD, panic disorder; TMT‐A, Trail Making Test‐Part A.

a

Mean (SD).